Chemical synthesis and characterization of silver-protected vasoactive intestinal peptide nanoparticles

被引:20
作者
Fernandez-Montesinos, Rafael [1 ,3 ]
Castillo, Paula M. [1 ,2 ,3 ]
Klippstein, Rebecca [1 ]
Gonzalez-Rey, Elena [1 ,3 ]
Mejias, Jose A. [2 ]
Zaderenko, Ana P. [2 ]
Pozo, David [1 ,3 ]
机构
[1] CABIMER, Andalusian Ctr Mol Biol & Regenerat Med, Seville, Spain
[2] Univ Pablo de Olavide, Seville, Spain
[3] Univ Seville, Seville, Spain
关键词
bioimaging; immune system; inflammation; microglia; neurodegeneration; neuropeptide; silver nanoparticle; theranostic agent; CYCLASE-ACTIVATING POLYPEPTIDE; N-TERMINAL ECTODOMAIN; HUMAN VPAC1 RECEPTOR; GOLD NANOPARTICLES; ANTIINFLAMMATORY NEUROPEPTIDES; THERAPEUTIC APPROACH; IMMUNE TOLERANCE; VIP; CELLS; CANCER;
D O I
10.2217/NNM.09.79
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We characterized a method to conjugate functional silver nanoparticles with vasoactive intestinal peptide (VIP), which could be used as a working model for further tailor-made applications based on VIP surface functionality. Despite sustained interest in the therapeutic applications of VIP, and the fact that its drugability could be largely improved by the attachament to functionalized metal nanoparticles, no methods have been described so far to obtain them. Materials & methods: VIP was conjugated to tiopronin-capped silver nanoparticles of a narrow size distribution, by means of proper linkers, to obtain VIP functionalized silver nanoparticles with two different VIP orientations (Ag-tiopronin-PEG-succinic-[His]VIP and Ag-tiopronin-PEG-VIP[His]). VIP intermediate nanoparticles were characterized by transmission-electron microscopy and Fourier transform infrared spectroscopy. VIP functionalized silver nanoparticles cytotoxicity was determined by lactate dehydrogenase release from mixed glial cultures prepared from cerebral cortices of 1-3 days-old C57/Bl mice. Cells were used for lipopolysaccharide stimulation at day 18-22 of culture. Results: Two different types of VIP-functionalized silver nanoparticles were obtained; both expose the C-terminal part of the neuropeptide, but in the first type VIP is attached to silver nanoparticle through its free amine terminus (Ag-tiopronin-PEG-succinic-[His]VIP), while in the second type, VIP N-terminus remains free (Ag-tiopronin-PEG-VIP[His]). VIP-functionalized silver nanoparticles did not compromise cellular viability and inhibited microglia-induced stimulation under inflammatory conditions. Conclusion: The chemical synthesis procedure developed to obtain VIP-functionalized silver nanoparticles rendered functional products, in terms of biological activity. The two alternative orientations designed, reduced the constraints for chemical synthesis that depends on the nanosurface to be functionalized. Our study provides, for the first time, a proof of principle to enhance the therapeutic potential of VIP with the valuable properties of metal nanoparticles for imaging, targeting and drug delivery.
引用
收藏
页码:919 / 930
页数:12
相关论文
共 73 条
  • [1] Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders
    Anderson, Per
    Delgado, Mario
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2008, 12 (5B) : 1830 - 1847
  • [2] Bally M, 2009, NANOMEDICINE-UK, V4, P447, DOI [10.2217/nnm.09.16, 10.2217/NNM.09.16]
  • [3] Gold nanoparticles inhibit VEGF165-induced proliferation of HUVEC cells
    Bhattacharya, R
    Mukherjee, P
    Xiong, Z
    Atala, A
    Soker, S
    Mukhopadhyay, D
    [J]. NANO LETTERS, 2004, 4 (12) : 2479 - 2481
  • [4] Nanotechnology in biology: big collaborations for a small world
    Blow, Nathan
    [J]. NATURE METHODS, 2008, 5 (06) : 569 - 574
  • [5] Inflammation and Cancer: IL-6 and STAT3 Complete the Link
    Bromberg, Jacqueline
    Wang, Timothy C.
    [J]. CANCER CELL, 2009, 15 (02) : 79 - 80
  • [6] Autophagy and neuropeptides at the crossroad for parasites to survive or to die
    Campos-Salinas, Jenny
    Gonzalez-Rey, Elena
    [J]. AUTOPHAGY, 2009, 5 (04) : 551 - 554
  • [7] Tiopronin monolayer-protected silver nanoparticles modulate IL-6 secretion mediated by Toll-like receptor ligands
    Castillo, Paula M.
    Herrera, Juan L.
    Fernandez-Montesinos, Rafael
    Caro, Carlos
    Zaderenko, Ana P.
    Mijias, Jose A.
    Pozo, David
    [J]. NANOMEDICINE, 2008, 3 (05) : 627 - 635
  • [8] The vasoactive intestinal peptide (VIP) α-helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/Pituitary adenylate cyclase-activating peptide 1 receptor:: Photoaffinity, molecular modeling, and dynamics
    Ceraudo, Emilie
    Murail, Samuel
    Tan, Yossan-Var
    Lacapere, Jean-Jacques
    Neumann, Jean-Michel
    Couvineau, Alain
    Laburthe, Marc
    [J]. MOLECULAR ENDOCRINOLOGY, 2008, 22 (01) : 147 - 155
  • [9] The N-Terminal Parts of VIP and Antagonist PG97-269 Physically Interact with Different Regions of the Human VPAC1 Receptor
    Ceraudo, Emilie
    Tan, Yossan-Var
    Nicole, Pascal
    Couvineau, Alain
    Laburthe, Marc
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2008, 36 (1-3) : 245 - 248
  • [10] Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity
    Connor, EE
    Mwamuka, J
    Gole, A
    Murphy, CJ
    Wyatt, MD
    [J]. SMALL, 2005, 1 (03) : 325 - 327